Herd Immunity : The Journey Is as Important as the Destination
| Errataetall: |
CommentOn: J Infect Dis. 2021 Sep 17;224(6):938-948. - PMID 33954775 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:224 |
|---|---|
| Enthalten in: |
The Journal of infectious diseases - 224(2021), 6 vom: 17. Sept., Seite 931-933 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Heaton, Penny M [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 vaccine |
|---|
| Anmerkungen: |
Date Completed 22.09.2021 Date Revised 22.09.2021 published: Print CommentOn: J Infect Dis. 2021 Sep 17;224(6):938-948. - PMID 33954775 Citation Status MEDLINE |
|---|
| doi: |
10.1093/infdis/jiab234 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM32506931X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM32506931X | ||
| 003 | DE-627 | ||
| 005 | 20231225191644.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/infdis/jiab234 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1083.xml |
| 035 | |a (DE-627)NLM32506931X | ||
| 035 | |a (NLM)33954748 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Heaton, Penny M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Herd Immunity |b The Journey Is as Important as the Destination |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.09.2021 | ||
| 500 | |a Date Revised 22.09.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentOn: J Infect Dis. 2021 Sep 17;224(6):938-948. - PMID 33954775 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Editorial | |
| 650 | 4 | |a Comment | |
| 650 | 4 | |a COVID-19 vaccine | |
| 650 | 4 | |a clinical benefit of COVID-19 vaccines | |
| 650 | 4 | |a economic benefit of COVID-19 vaccines | |
| 650 | 4 | |a vaccine hesitancy | |
| 650 | 4 | |a vaccine providers | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of infectious diseases |d 1945 |g 224(2021), 6 vom: 17. Sept., Seite 931-933 |w (DE-627)NLM000005819 |x 1537-6613 |7 nnns |
| 773 | 1 | 8 | |g volume:224 |g year:2021 |g number:6 |g day:17 |g month:09 |g pages:931-933 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/infdis/jiab234 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 224 |j 2021 |e 6 |b 17 |c 09 |h 931-933 | ||